Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antipsychotic-induced weight gain.

A J Goudie1, G D Cooper, J C G Halford

  • 1School of Psychology, Liverpool University, Liverpool, UK. ajg@liverpool.ac.uk

Diabetes, Obesity & Metabolism
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental life cycle assessment of production of the high intensity sweetener steviol glycosides from <i>Stevia rebaudiana</i> leaf grown in Europe: The SWEET project.

The international journal of life cycle assessment·2023
Same author

Learning in lockdown: Using the COVID-19 crisis to teach children about food and climate change.

Nutrition bulletin·2021
Same author

Differences in parental feeding styles and practices and toddler eating behaviour across complementary feeding methods: Managing expectations through consideration of effect size.

Appetite·2019
Same author

Systematic review of the evidence for sustained efficacy of dietary interventions for reducing appetite or energy intake.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Response to 'Jangle fallacy epidemic in obesity research: a comment on Ruddock et al. (2017)'.

International journal of obesity (2005)·2017
Same author

Response to "How much does the Addiction-Like eating behaviour scale add to the debate regarding food versus eating addictions?"

International journal of obesity (2005)·2017
Same journal

Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial.

Diabetes, obesity & metabolism·2026
Same journal

Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.

Diabetes, obesity & metabolism·2026
Same journal

First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.

Diabetes, obesity & metabolism·2026
Same journal

Trends in Prevalence of Diabetes, Pre-Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013-2023.

Diabetes, obesity & metabolism·2026
Same journal

Metabolic Risk-Attributable Dementia Burden: A Life-Course and Cautious Attribution Perspective.

Diabetes, obesity & metabolism·2026
Same journal

A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.

Diabetes, obesity & metabolism·2026
See all related articles

Novel antipsychotic drugs offer benefits but can cause significant weight gain, impacting patient health and treatment adherence. This review examines atypical antipsychotic weight gain, its causes, and animal models for future research.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Medicine

Background:

  • Atypical antipsychotic medications represent advancements over typical antipsychotics.
  • A subset of atypical antipsychotics is associated with significant weight gain, affecting patient adherence and health outcomes.
  • Understanding the mechanisms behind this adverse drug reaction is crucial for improving patient care.

Purpose of the Study:

  • To review the differential weight gain potential of various atypical antipsychotics.
  • To explore the neurochemical underpinnings (neurotransmitters and neuropeptides) of atypical antipsychotic-induced weight gain.
  • To assess the current status and future directions of animal models for studying this phenomenon.

Main Methods:

  • Literature review and synthesis of existing research on atypical antipsychotics and weight gain.

Related Experiment Videos

  • Analysis of clinical data and pharmacological studies.
  • Evaluation of the utility and limitations of animal models in preclinical research.

    • Main Results:

    • Significant variability exists in the propensity of different atypical antipsychotics to cause weight gain.
    • Neurotransmitter and neuropeptide systems, including serotonin, dopamine, and histamine, are implicated in weight regulation.
    • Animal models are under development but require further refinement to accurately predict human responses.

    Conclusions:

    • Weight gain is a critical side effect of some atypical antipsychotics, necessitating careful patient monitoring and drug selection.
    • Further research into the neurobiological mechanisms is needed to develop strategies for mitigating weight gain.
    • Improved animal models are essential for advancing the development of safer and more effective antipsychotic treatments.